title: U.S. Food and Drug Administration. "Evaluation Criteria" for Difficult to Compound Drugs.
abstract: This is part 2 of a 2-part article on the topic of Nominations of Difficult to Compound Drugs to the FDA-PCAC. Part 1 provided a current list of Nominations of Difficult to Compound Drugs to the FDA-PCAC. This article discusses the evaluation procedure for determining which drugs are demonstrably difficult to compound.
authors.forename: Loyd V
authors.initials: LV
authors.lastname: Allen
mesh_terms: D004304:Dosage Forms; D004339:Drug Compounding / Q000379:methods*; D004364:Pharmaceutical Preparations / Q000737:chemistry* / Q000145:classification; D009626:Terminology as Topic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004304:Dosage Forms; D004364:Pharmaceutical Preparations